Nrf2-IN-4
Nrf2-IN-4 is a Nrf2 inhibitor. Nrf2-IN-4 induces ferroptosis via NRF2 inhibition. Nrf2-IN-4 disrupts cellular iron homeostasis, facilitates ferritin degradation, and ultimately triggers ferroptosis. Nrf2-IN-4 induces lysosome activation by promoting iron-dependent ROS production and lysosomal acidification. Nrf2-IN-4 demonstrates significant antitumor efficacy. Nrf2-IN-4 can be used for the study of breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 2417486-06-5
- Formula: C20H13Cl2N5S
- Molecular Weight:426.32
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Nrf2-IN-4 (Compound PhcY) (0.01-10 μM, 72 h) exhibits inhibitory effect on the cancer cell lines, with IC50s of 80 nM (MCF-7 cells), 3.26 μM (HepG2 cells), 0.90 μM (T24 cells), 2.89 μM (HCT116 cells), 3.27 μM (L929 fibroblasts) and 5.36 μM (HEK293 human embryonic kidney cells)[1]. Nrf2-IN-4 (40-160 nM) causes MCF-7 cells to exhibit ‘ballooning’ and rounded cell morphology with vacuolated cytosol[1]. Nrf2-IN-4 (40-80 nM, 14 days) inhibits colony formation of MCF-7 cells in a dose-dependent manner[1]. Nrf2-IN-4 (80-160 nM, 24-48 h) increases labile iron pool (LIP) and ferroptosis via inhibition of Nrf2 in MCF-7 cells[1]. Nrf2-IN-4 (80-320 nM, 24 h) induces lysosome activation by promoting iron-dependent ROS production and lysosomal acidification in MCF-7 cells[1]. Nrf2-IN-4 (40-320 nM, 0-12 h) induces ferritin degradation via ferritinophagy in MCF-7 cells[1]. Nrf2-IN-4 (80-320 nM) induces oxidative stress, resulting in a significant decrease in mitochondrial membrane potential, an effect that can be reduced by the Acetylcysteine (N-acetylcysteine) (NAC) (HY-B0215) in MCF-7 cells[1]. Nrf2-IN-4 (0.1-0.2 μM) demonstrates a potent inhibitory effect on organoid growth, surpassing the efficacy of ML385(HY-100523)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF-7 cells
-
Concentration:80 nM
-
Incubation Time:24 h
-
Result:Increased LIP and reversed the effect and the the effect was reversed by Nrf2 knockdown.
-
Cell Line:MCF-7 cells
-
Concentration:80, 160 nM
-
Incubation Time:48 h
-
Result:Increased cytotoxicity upon Nrf2 overexpression. Induced dose-dependent cytotoxicity, which was inhibited by both 1,8-Diazafluoren-9-one (DFO) (HY-D0903) and Ferrostatin-1 (Fer-1) (HY-100579).
-
Cell Line:MCF-7 cells
-
Concentration:80, 160, 320 nM
-
Incubation Time:24 h
-
Result:Increased cathepsin B activity in a dose-dependent manner, which was inhibited by Chloroquine (CQ)(HY-17589A) or DFO.
-
Cell Line:MCF-7 cells
-
Concentration:0, 3, 6, 9, 12 h
-
Incubation Time:24 h
-
Result:Showed a dose-dependent increase in Beclin-1, LC3-II, and ATG5 protein levels. Reduced intracellular FTH and FTL levels, and this reduction was reversed by autophagy inhibitors(Bafilomycin A1(HY-100558) ,CQ) and the iron chelator DFO.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MCF-7 cells (5 × 106) were injected subcutaneously into each female adult athymic nude mouse [1]
-
Dosage:10 mg/kg
-
Administration:i.p. daily for 21 days
-
Result:Led to the degradation of FTH and FTL, as well as the upregulation of P53 and LC3-II. Did not cause notable body weight loss or other observable adverse effects in mice.
Chemical Information
-
CAS No. 2417486-06-5
-
Molecular Weight 426.32
-
Formula C20H13Cl2N5S
-
SMILES
ClC1=C(Cl)C=C(C2=CSC(N/N=C(C3=CC=CC=N3)/C4=NC=CC=C4)=N2)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Patient-Derived Xenograft (PDX)
Patient-derived xenograft (PDX) models are generated by engrafting primary human tumor tissue directly into immunodeficient mice, allowing in vivo propagation of patient tumor biology without initial in vitro adaptation. These models are used to preserve key histopathological and molecular characteristics of the original tumor and enable assessment of tumor growth dynamics and therapeutic response in a living organism. The biological readout is tumor engraftment and subsequent growth in the murine host, which reflects the ability of human tumor cells to survive, vascularize, and expand in an immunocompromised microenvironment.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)